Results 1 to 10 of about 9,800 (200)

Diagnosis of patients with hemoglobinopathies including α-thalassemia in a laboratory with limited resources

open access: diamondIraqi Journal of Hematology, 2020
BACKGROUND: Diagnosis of α-thalassemia can be challenging as it is clinically insignificant in the majority of patients who are presented with one or two α-gene deletion, it cannot be always suspected from the red cell indices, and the confirmatory tests
Abbas Hashim Abdulsalam   +2 more
doaj   +2 more sources

Knowledge, Attitude, and Practice of Sickle Cell Disease Among Sickle Cell Disease Patients in Sudurpashchim Province of Nepal: A Cross‐Sectional Study [PDF]

open access: yesHealth Science Reports
Background Sickle cell disease (SCD) is a genetic hemoglobinopathy which is responsible for about 3.5% of deaths in
Gauri Datt Joshi   +14 more
doaj   +2 more sources

An overview of complications associated with deferoxamine therapy in thalassemia [PDF]

open access: yesJournal of Nephropharmacology, 2021
Thalassemic syndromes are the most common genetic diseases in the world that are related to blood transfusion and iron overload in the body. In ß-thalassemia major multiple blood transfusions due to ineffective erythropoiesis lead to iron excess in the ...
Bijan Keikhaei   +5 more
doaj   +1 more source

COVID-19 and Hemoglobinopathies: A Systematic Review of Clinical Presentations, Investigations, and Outcomes

open access: yesFrontiers in Medicine, 2021
This systematic review aimed to provide an overview of the clinical profile and outcome of COVID-19 infection in patients with hemoglobinopathy. The rate of COVID-19 mortality and its predictors were also identified.
Jun Xin Lee   +3 more
doaj   +1 more source

A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention

open access: yesTurkish Journal of Hematology, 2018
Objective: The Turkish Society of Pediatric Hematology set up a National Hemoglobinopathy Registry to demonstrate the demographic and disease characteristics of patients and assess the efficacy of a hemoglobinopathy control program (HCP) over 10 years in
Yeşim Aydınok   +35 more
doaj   +1 more source

Ferritin thresholds for cardiac and liver hemosiderosis in β-thalassemia patients: a diagnostic accuracy study

open access: yesScientific Reports, 2022
Ferritin is frequently used to screen some dire consequences of iron overload in β-thalassemia patients. The study aimed to define the best cutoff point of ferritin to screen for cardiac and liver hemosiderosis in these cases.
Hadi Darvishi-Khezri   +7 more
doaj   +1 more source

Time to Do Something for Vitamin D Deficiency; A Review

open access: yesJournal of Pediatrics Review, 2015
Context: Vitamin D deficiency is a common nutritional disorder in Iran. Vitamin D is an essential health factor from birth onward. This study was conducted to summarize epidemiologic researches regarding vitamin D deficiency in different parts of the ...
Mehrnoush Kosaryan   +3 more
doaj   +3 more sources

Early Screening of Hemoglobinopathy in Indonesia Using Erythrocyte Indices

open access: yesIndonesian Biomedical Journal, 2017
BACKGROUND: The mutation spectrums of hemoglobinopathy are different among populations that yield a different result of erythrocyte indices. Calculation of erythrocyte indices with some formula has been reported to differentiate between hemoglobinopathy ...
Yenny Surjawan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy